Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
01/15/2009 | WO2009008466A1 Phosphatidate phosphatase homolog and use of the same |
01/15/2009 | WO2009008414A1 Monoclonal antibody having neutralizing activity against mmp13 |
01/15/2009 | WO2009007982A1 A conserved region of the hiv-1 genome and uses thereof |
01/15/2009 | WO2009007979A2 Encapsulated mesenchymal stem cells and uses thereof |
01/15/2009 | WO2009007852A2 Multipotent/pluripotent cells and methods |
01/15/2009 | WO2009007618A2 Tumour-cell-fixing cells |
01/15/2009 | WO2009007503A1 Delivery of nucleic acids into genomes of human stem cells using in vitro assembled mu transposition complexes |
01/15/2009 | WO2009007120A2 Tnf superfamily collectin fusion proteins |
01/15/2009 | WO2009006997A1 Human pluripotent stem cells and their medical use |
01/15/2009 | WO2009006930A1 Human pluripotent stem cells induced from undifferentiated stem cells derived from a human postnatal tissue |
01/15/2009 | WO2009006782A1 CLONING TRANSCRIPTION FACTOR GENE OsWOX20 THAT REGULATES THE GROWTH AND DEVELOPMENT OF MONOCOTYLEDON'S ROOT AND USES THEREOF |
01/15/2009 | WO2009006751A1 Neurons and methods for preparing them |
01/15/2009 | WO2008148105A8 Endometrial stem cells and methods of making and using same |
01/15/2009 | WO2008144580A3 Primate stem cells produced by somatic cell nuclear transfer |
01/15/2009 | WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof |
01/15/2009 | WO2008124166A3 Fusion proteins of collagen-binding domain and parathyroid hormone |
01/15/2009 | WO2008110578A3 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts |
01/15/2009 | WO2008098942A3 Process and support structure for the cultivation of living cells |
01/15/2009 | WO2008097854A4 Method and substances for treating hpv infection |
01/15/2009 | WO2008017598A3 Citrusal aroma receptors and use of myrac aldehyde derivatives for increasing the flagellation frequency of a spermatozoon |
01/15/2009 | WO2007117602A3 Isolation and use of human regulatory t cells |
01/15/2009 | US20090019608 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
01/15/2009 | US20090019607 Transgenic plant cells expressing a transcription factor |
01/15/2009 | US20090019604 Soybean variety d4203144 |
01/15/2009 | US20090019603 Soybean variety d4696658 |
01/15/2009 | US20090019595 Soybean variety d4102367 |
01/15/2009 | US20090019594 Soybean variety d4266582 |
01/15/2009 | US20090019593 Soybean variety d4422801 |
01/15/2009 | US20090019592 Soybean variety d4356652 |
01/15/2009 | US20090019591 Soybean variety d4456885 |
01/15/2009 | US20090019590 Soybean variety d4698013 |
01/15/2009 | US20090019589 Soybean variety d4637114 |
01/15/2009 | US20090019588 Soybean variety d4520980 |
01/15/2009 | US20090019587 Soybean variety d4521369 |
01/15/2009 | US20090019586 Soybean variety d4223057 |
01/15/2009 | US20090019585 Soybean variety d4682156 |
01/15/2009 | US20090019584 Soybean variety d4233569 |
01/15/2009 | US20090019583 Soybean variety d4925614 |
01/15/2009 | US20090019582 Soybean variety d4102536 |
01/15/2009 | US20090019578 Soybean variety d4258962 |
01/15/2009 | US20090019577 Soybean variety d4253969 |
01/15/2009 | US20090019576 Soybean variety d4256925 |
01/15/2009 | US20090019575 Soybean variety d4253681 |
01/15/2009 | US20090019574 Soybean variety d4789254 |
01/15/2009 | US20090019573 Soybean variety d4713125 |
01/15/2009 | US20090019570 Soybean variety d4012368 |
01/15/2009 | US20090019561 Pepper Hybrid E 499531 |
01/15/2009 | US20090019560 Removing ovocyte and placing in proteasome inhibitor solution to prevent activation, transferring nucleus of donor cell, activating and implanting into uterus of recipient; producing animal models |
01/15/2009 | US20090019558 Pgds as modifiers of the pten pathway and methods of use |
01/15/2009 | US20090019554 Targeted cell death |
01/15/2009 | US20090018868 Method for Utilizing Cell Therapy Product Facility and Network-Based Business Model Using the Same |
01/15/2009 | US20090018218 METHODS OF MODIFYING AMYLOID beta OLIGOMERS USING NON-PEPTIDIC COMPOUNDS |
01/15/2009 | US20090018099 Protein production |
01/15/2009 | US20090018097 Modification of double-stranded ribonucleic acid molecules |
01/15/2009 | US20090018096 Methods For Regulating The Growth And/Or Survival Of Tumor Cells And Stem Cells By Modulating The Expression Or Function Of The Transcription Factor ATF5 |
01/15/2009 | US20090018088 Treating cancer with cardiac glycosides |
01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
01/15/2009 | US20090018071 Epididymis-specific receptor protein |
01/15/2009 | US20090018070 Fsh Mutants |
01/15/2009 | US20090018068 G-protein coupled receptors |
01/15/2009 | US20090018067 Regulatory t cell epitopes, compositions and uses thereof |
01/15/2009 | US20090018063 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
01/15/2009 | US20090018059 Method for maintaining pluripotency of stem/progenitor cells |
01/15/2009 | US20090018033 Cell Aggregation and Encapsulation Device and Method |
01/15/2009 | US20090018016 Bacterial glutamine synthetases and methods of use |
01/15/2009 | US20090017557 FVII Specific Antibodies and Use Thereof |
01/15/2009 | US20090017542 producing high titer, wild-type-free preparations of recombinant AAV (adeno-associated virus) virions; for use as tools in genetic engineering and gene therapy |
01/15/2009 | US20090017541 Porous Sheet-Form Material For Cell Culture, And Bioreactor And Culturing Method Utilizing Same |
01/15/2009 | US20090017540 Method of culturing cells under regulation in the extension direction |
01/15/2009 | US20090017539 Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics |
01/15/2009 | US20090017538 For modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein |
01/15/2009 | US20090017537 hT2R54 Receptor Polypeptides and Nucleic Acid Sequences |
01/15/2009 | US20090017536 Modified vaccinia ankara virus variant and cultivation method |
01/15/2009 | US20090017535 Biomarkers; fusion proteins |
01/15/2009 | US20090017534 Nucleotide sequences coding voltage-gated transport proteins for use as screening tools to identify modulators for treatment and prevention of nervous, muscular, glandular, immune, reproductive and epithelial tissue disorders |
01/15/2009 | US20090017533 Optimized messenger rna |
01/15/2009 | US20090017522 proteolytic fragment of a growth differentiation factor (GDF) polypeptide (pro-GDF) or a functional peptide portion thereof; affects activity associated with GDF signal transduction |
01/15/2009 | US20090017508 Streptomyces Avermitilis Gene Directing The Ratio of B2:B1 Avermectins |
01/15/2009 | US20090017498 Fibroblast Growth Factor-Like Polypeptides |
01/15/2009 | US20090017494 Tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
01/15/2009 | US20090017492 SVPH1-26 DNA and polypeptides |
01/15/2009 | US20090017490 DNA Fragment Method for Producing Transformant for Protein Production and Utilization Thereof |
01/15/2009 | US20090017489 Methods For Modulating The Development Of Dopamine Neuron By The Dopamine D2 Receptor And Compositions Thereof |
01/15/2009 | US20090017465 Compound Screening Using Cardiomyocytes |
01/15/2009 | US20090017460 Differential expression profiling analysis of cell culture phenotypes and uses thereof |
01/15/2009 | US20090017440 Increasing the viability and stress tolerance of viable biological material |
01/15/2009 | US20090017439 Compositions and methods for enhancing the viability of animal cells, tissues, and organ explants |
01/15/2009 | US20090017438 Methods and compositions for the preservation of cells and tissues |
01/15/2009 | US20090017437 Fixative composition |
01/15/2009 | US20090017106 Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositions |
01/15/2009 | US20090017092 Novel Class of Cell-Interactive Material and Process of Preparation of Artificial Tissues of Human and Animal Origin |
01/15/2009 | US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
01/15/2009 | US20090017070 In vitro model for hepatitis c virion production |
01/15/2009 | US20090017068 Vaccines against West Nile Virus |
01/15/2009 | US20090017065 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
01/15/2009 | US20090017054 nucleic acids corresponding to entire coding sequences of S. pneumoniae proteins, including surface or secreted proteins or parts thereof; for diagnostics, prophylaxis and treatment of bacterial infection; vaccines |
01/15/2009 | US20090017049 BetaGBP, compositions comprising betaGBP, and related methods and uses thereof |
01/15/2009 | US20090017048 Novel Brachyspira hyodysenteriae vaccine |
01/15/2009 | US20090017044 Antibodies to the Human Prolactin Receptor |